STING was found to be relatively highly expressed in acute myeloid leukemia (AML) and chronic myeloid leukemia, with higher STING expression correlated with poorer prognosis in AML. The gene discussed is STING1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.